blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0876153

EP0876153 - MEDICAL USE OF PROTEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.11.2001
Database last updated on 28.09.2024
Most recent event   Tooltip02.11.2001Application deemed to be withdrawnpublished on 19.12.2001 [2001/51]
Applicant(s)For all designated states
Cortecs (UK) Limited
The Old Blue School, Lower Square Isleworth
Middlesex TW7 6RL / GB
[N/P]
Former [1998/46]For all designated states
Cortecs (UK) Limited
The Old Blue School, Lower Square
Isleworth, Middlesex TW7 6RL / GB
Inventor(s)01 / MYNOTT, Tracey, L.-Imp. Col. of Scie., Tec.& Med.
nDept. of Biochemistry - Exhibition Road
London SW7 2AZ / GB
02 / ENGWERDA, C.-London School of Hyg. & Tropic. Med.
Dept. of Medical Parasitology - Keppel Street
London WC1E 7HT / GB
[1998/46]
Representative(s)Chapman, Paul William, et al
Kilburn & Strode LLP
20 Red Lion Street
London
WC1R 4PJ / GB
[N/P]
Former [1998/46]Chapman, Paul William, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date96942449.813.12.1996
[1998/46]
WO1996GB03089
Priority number, dateGB1995002669129.12.1995         Original published format: GB 9526691
[1998/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9724138
Date:10.07.1997
Language:EN
[1997/30]
Type: A2 Application without search report 
No.:EP0876153
Date:11.11.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 10.07.1997 takes the place of the publication of the European patent application.
[1998/46]
Search report(s)International search report - published on:EP16.10.1997
ClassificationIPC:A61K38/43
[1998/46]
CPC:
A61K38/4826 (EP); A61K38/4873 (EP); A61K39/39 (EP);
A61P31/00 (EP); A61P33/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
C12Y304/21004 (EP); C12Y304/22002 (EP); A61K2039/55516 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/46]
Extension statesSI28.07.1998
TitleGerman:MEDIZINISCHE VERWENDUNG VON PROTEASEN[1998/46]
English:MEDICAL USE OF PROTEASES[1998/46]
French:UTILISATION MEDICALE DE PROTEASES[1998/46]
Entry into regional phase28.07.1998National basic fee paid 
28.07.1998Designation fee(s) paid 
28.07.1998Examination fee paid 
Examination procedure29.07.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.07.1998Examination requested  [1998/46]
29.09.1998Amendment by applicant (claims and/or description)
26.01.2001Despatch of a communication from the examining division (Time limit: M04)
06.06.2001Application deemed to be withdrawn, date of legal effect  [2001/51]
10.07.2001Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2001/51]
Fees paidRenewal fee
11.12.1998Renewal fee patent year 03
09.12.1999Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.12.200005   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DPY]WO9600082  (CORTECS LTD [GB], et al) [DPY] 1-6 * the whole document *
 [XY]  - ELENA GABRIELESCU, "An integrative approach to the proteolytic control of the cell-mediated cytotoxicity", ROUM. ARCH. MICROBIOL. IMMUNOL., (1992), vol. 51, no. 1-2, pages 33 - 51, XP000652932 [X] 1,2,6 * abstract * * page 33 - page 34 * * page 41 * * page 44 - page 45 * [Y] 3-5
 [XY]  - "Systematische Enzymtherapie: Grosse Zukunft zu erwarten", THERAPIEWOCHE ÖSTERREICH, (1992), vol. 7, no. 2, pages 65 - 72, XP000652911 [X] 6 * page 66 - page 68 * [Y] 1-5
 [XY]  - G.STAUDER, "Pharmacological effects of oral enzyme combinations", CASOPIS LEKARU CESKYCH, (1995), vol. 134, no. 19, pages 620 - 624, XP000652595 [X] 6 * the whole document * [Y] 1-5
 [X]  - M.T.ALONSO ET AL., "Leupeptin does not affect the normal signal transduction mechanism in platelets", FEBS LETT., (1989), vol. 244, no. 2, pages 407 - 410, XP000652613 [X] 1 * abstract *

DOI:   http://dx.doi.org/10.1016/0014-5793(89)80573-3
 [X]  - DARIO C. ALTIERI, "Proteases and protease receptors in modulation of leukocyte effector functions", J. LEUKOC. BIOL., (1995), vol. 58, no. 2, pages 120 - 127, XP000652620 [X] 1-3 * abstract * * page 122, column L; tables 1,2 *
 [X]  - DENIS GODIN ET AL., "Mode of action of thrombin in the rat aorta", BR. J. PHARMACOL., (199507), vol. 115, no. 6, pages 903 - 908, XP000652621 [X] 1 * abstract *
 [Y]  - A.GESCHER, "Modulators of signal transduction as cancer chemotherapeutic agents - novel mechanisms and toxicities", TOXICOLOGY LETTERS, (199512), vol. 82/83, pages 159 - 163, XP000652605 [Y] 1-6 * abstract *

DOI:   http://dx.doi.org/10.1016/0378-4274(95)03475-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.